Did you mean: KABoki
COVID-19 infection among autoimmune rheumatic disease patients: data from an observational study and literature review
The impact of SARS-CoV-2 infection in patients with autoimmune/auto-inflammatory rheumatic
diseases (AARD) under immunomodulatory treatment has been a focus of interest during …
diseases (AARD) under immunomodulatory treatment has been a focus of interest during …
[HTML][HTML] Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide
JPA Ioannidis, KA Boki, ME Katsorida, AA Drosos… - Kidney international, 2000 - Elsevier
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide.
Background Long-term intravenous cyclophosphamide (IVC) in combination with …
Background Long-term intravenous cyclophosphamide (IVC) in combination with …
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
…, M Kokosi, A Tzioufas, SP Toya, KA Boki… - European …, 2010 - Eur Respiratory Soc
We sought to determine the type of pulmonary involvement in microscopic polyangiitis (MPA),
primarily focusing on pulmonary fibrosis (PF), its prevalence, temporal relationship with …
primarily focusing on pulmonary fibrosis (PF), its prevalence, temporal relationship with …
Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis
Among 14 randomised patients with proliferative lupus nephritis, monthly intravenous
immunoglobulin maintained remission over 18 months, similar to standard intravenous …
immunoglobulin maintained remission over 18 months, similar to standard intravenous …
Risk factors for central nervous system involvement in systemic lupus erythematosus
We investigated risk factors for central nervous system (CNS) involvement in systemic lupus
erythematosus (SLE), in 32 such patients individually matched 1 : 3 to 96 control SLE …
erythematosus (SLE), in 32 such patients individually matched 1 : 3 to 96 control SLE …
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of …
I Flouri, TE Markatseli, PV Voulgari, KA Boki… - Seminars in arthritis and …, 2014 - Elsevier
… Boki MD c , Ioannis Papadopoulos MD d , Loukas Settas MD e , Dimitrios Zisopoulos MD
e f , Fotini N. Skopouli MD g , Alexios Iliopoulos MD h , George K. Bertsias MD a , Pierre …
e f , Fotini N. Skopouli MD g , Alexios Iliopoulos MD h , George K. Bertsias MD a , Pierre …
Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus
PURPOSE: We sought to identify the predictors of clinical outcome and of the evolution of
cerebral abnormalities in patients with neuropsychiatric systemic lupus erythematosus (SLE). …
cerebral abnormalities in patients with neuropsychiatric systemic lupus erythematosus (SLE). …
The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients …
…, NG Tzortzakis, E Panou-Pomonis, KA Boki… - Annals of the …, 2000 - ard.bmj.com
OBJECTIVES To develop an enzyme linked immunosorbent assay (ELISA) using as substrate
a synthetic 22-aminoacid peptide, corresponding to the ribosomal P0, P1 and P2 common …
a synthetic 22-aminoacid peptide, corresponding to the ribosomal P0, P1 and P2 common …
[PDF][PDF] Is the heart affected in primary Sjogren's syndrome? An echocardiographic study
VA Vassiliou, I Moyssakis, KA Boki… - Clinical and …, 2008 - clinexprheumatol.org
Objective. To evaluate whether patients with primary Sjögren’s syndrome with-’out overt
cardiac disease have echocardiographic abnormalities and their relation with clinical and …
cardiac disease have echocardiographic abnormalities and their relation with clinical and …
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome
MG Tektonidou, JPA Ioannidis, KA Boki… - Qjm, 2000 - academic.oup.com
We assessed whether initial clinical presentations suggestive of antiphospholipid syndrome
(APS) predicted the subsequent rate and type of serious clinical outcomes. Eighty‐two …
(APS) predicted the subsequent rate and type of serious clinical outcomes. Eighty‐two …
Did you mean to search for: KABoki